⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11664747 | 0.97 | — | — | |
| SCHEMBL18399381 | 0.84 | — | — | |
| SCHEMBL1473105 | 0.84 | — | — | |
| SCHEMBL948275 | 0.74 | — | — | |
| SCHEMBL13025219 | 0.73 | — | — | |
| Diethyl Sulfide SCHEMBL9422733 | 0.72 | — | — | |
| SCHEMBL172375 | 0.69 | — | — | |
| SCHEMBL12581475 | 0.69 | — | — | |
| SCHEMBL8037710 | 0.69 | — | — | |
| SCHEMBL1451276 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230286904-A1 | INHIBITORS OF YAP/TAZ-TEAD ONCOPROTEINS, SYNTHESIS AND USE THEREOF | BRIDGENE BIOSCIENCES, INC. | 2023-09-14 | — | — | US | disclosed |
| EP-1921077-B1 | AGENT FOR TREATING AND/OR PREVENTING SLEEP DISORDER | KYOWA HAKKO KIRIN CO LTD (JP) | 2017-07-26 | — | — | EP | disclosed |
| WO-2017102475-A1 | PYRIDINE GROUP-CONTAINING ACYL HYDRAZONES | HENKEL AG & CO. KGAA (DE) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017102476-A1 | LIQUID DETERGENTS OR CLEANING AGENTS CONTAINING ACYL HYDRAZONE AND REDUCING AGENTS | HENKEL AG & CO. KGAA (DE) | 2017-06-22 | — | — | WO | disclosed |
| WO-2011044264-A2 | PYRROLOPYRAZOLES FOR TREATING CNS DISORDERS | AFRAXIS, INC. (US) | 2011-04-14 | — | — | WO | disclosed |
| US-7915441-B2 | Oligophosphazene compound | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2011-03-29 | — | — | US | disclosed |
| US-7780743-B2 | Fluorescent entity, dyeing composition containing at least one fluorescent entity, and method for lightening keratin materials using said at least one fluorescent entity | L'OREAL S.A. (FR) | 2010-08-24 | — | — | US | disclosed |
| US-20100160599-A1 | OLIGOPHOSPHAZENE COMPOUND | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20090320216-A1 | Fluorescent entity, dyeing composition containing at least one fluorescent entity, and method for lightening keratin materials using said at least one fluorescent entity | L'OREAL S.A. (FR) | 2009-12-31 | — | — | US | disclosed |
| WO-2009070693-A2 | MODULATORS OF OCULAR OXIDATIVE STRESS | SIRION THERAPEUTICS, INC (US) | 2009-06-04 | — | — | WO | disclosed |
| EP-1558579-B1 | N-ALKYL-4-METHYLENEAMINO-3-HYDROXY-2-PYRIDONES AS ANTIMICROBIALS | PROCTER & GAMBLE (US) | 2007-09-12 | — | — | EP | disclosed |